Heat Biologics (HTBX) Announces $1.5M Loan Paydown Following Warrant Exercise

October 7, 2016 7:00 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Heat Biologics, Inc. (“Heat”) (Nasdaq: HTBX) announced that it has paid down $1.5 million on its commercial loan following the recent exercise of warrants, which have generated $2.8 million in cash proceeds last quarter.

“We continue to strengthen our balance sheet and carefully manage expenses while pursuing an aggressive clinical program that will generate four important data readouts this quarter,” commented Jeff Wolf, Heat’s Founder and CEO.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Management Comments

Add Your Comment